NEUGENESIS CORPORATION

Company Information

Company Name
NEUGENESIS CORPORATION
Address
NEUGENESIS CORPORATION
871 INDUSTRIAL RD, STE J
SAN CARLOS, CA, 94070
Phone
1 650-508-9671
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$950,000.00
18
SBIR Phase II
$1,827,000.00
4
Chart code to be here

Award List

  1. RAPID APPROACHES FOR PRODUCTION OF GENOMIC DNA PROBES

    Amount: $332,000.00

    CURRENT METHODS TO ISOLATE CLUSTERS OF DNA FRAGMENTS LINKED TO A GIVEN MARKER ARE SLOW AND CUMBERSOME. METHODS FOR IN SITU HYBRIDIZATION OF UNIQUE' COPY GENE SEQUENCES TO HUMAN CHROMOSOMES ARE ALSO DI ...

    SBIR Phase II 1987 Department of Health and Human Services
  2. PRODUCTION OF COMPOSITE MONOCLONAL IMMUNOGLOBULINS

    Amount: $500,000.00

    MURINE MONOCLONAL ANTIBODIES ARE NOT USEFUL FOR REPEATED ADMINISTRATION TO MAN BECAUSE OF THE NUMBER OF FOREIGN ANTIGEN DETERMINANTS THEY CONTAIN. PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES WOULD BE DE ...

    SBIR Phase II 1985 Department of Health and Human Services
  3. NEW APPROACHES TO PRODUCTION OF HLA TYPING REAGENTS

    Amount: $495,000.00

    HUMAN CLASS II HISTOCOMPATIBILITY ANTIGEN TYPING IS ALREADY OF SUBSTANTIAL IMPORTANCE IN DETERMING DISEASE SUSCEPTIBILITY IN INDIVIDUALS. PRESENT SEROLOGIC METHODS OF CLASS II ANTIGEN TYPING ARE LIMIT ...

    SBIR Phase II 1986 Department of Health and Human Services
  4. INTERLEUKIN 2 (IL-2) IS A RELATIVELY WELL-STUDIED LYMPHOKINE THAT PROMOTES PROLIFERATION AND DIFFERENTIATION OF T LYMPHOCYTES AND NATURAL KILLER CELLS.

    Amount: $50,000.00

    INTERLEUKIN 2 (IL-2) IS A RELATIVELY WELL-STUDIED LYMPHOKINE THAT PROMOTES PROLIFERATION AND DIFFERENTIATION OF T LYMPHOCYTES AND NATURAL KILLER CELLS. IL-2 HAS POTENT ANTITUMOR EFFECTS WHEN ADMINISTE ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. WE WILL IDENTIFY AND CHARACTERIZE ALL THE MHC CLASS II BETA CHAIN GENES AND PSEUDOGENES IN A CELL LINE CONTAINING A SINGLE COPY OF THE MHC.

    Amount: $50,000.00

    WE WILL IDENTIFY AND CHARACTERIZE ALL THE MHC CLASS II BETA CHAIN GENES AND PSEUDOGENES IN A CELL LINE CONTAINING A SINGLE COPY OF THE MHC. THE SEQUENCE INFORMATION OBTAINED WILL BE USED TO CONSTRUCT ...

    SBIR Phase I 1985 Department of Health and Human Services
  6. THE OBJECTIVE IS TO DEVELOP AN IN VITRO IMMUNIZATION SYSTEM TO PRODUCE HUMAN MONOCLONAL ANTIBODIES TO CELL SURFACE ANTIGENS OF HUMAN BREAST CARCINOMA, COLON CARCINOMA, AND MALIGNANT MELANOMA.

    Amount: $50,000.00

    THE OBJECTIVE IS TO DEVELOP AN IN VITRO IMMUNIZATION SYSTEM TO PRODUCE HUMAN MONOCLONAL ANTIBODIES TO CELL SURFACE ANTIGENS OF HUMAN BREAST CARCINOMA, COLON CARCINOMA, AND MALIGNANT MELANOMA. HUMAN MO ...

    SBIR Phase I 1985 Department of Health and Human Services
  7. HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

    Amount: $500,000.00

    THE IMMUNE RESPONSE IN MAN IS REGULATED BY ORDERED INTERACTIONS BETWEEN FUNCTIONALLY AND PHENOTYPICALLY DISTINCT LYMPHOID CELLS (T CELLS AND THEIR SUBSETS, B CELLS AND MONOCYTES) IN THE CONTEXT OF IA- ...

    SBIR Phase II 1986 Department of Health and Human Services
  8. HUMAN T-CELL LYMPHOTROPHIC VIRUSES ARE COMPOSED OF AT LEAST THREE MEMBERS, INCLUDING THE HTLV-I VIRUS WHICH IS THE ETIOLOGIC AGENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA AND THE RECENTLY WELL-CHARACTERIZED HTLV-III (ARV, LAV) GENOME WHICH TRANSMITS ACQUIRED

    Amount: $50,000.00

    HUMAN T-CELL LYMPHOTROPHIC VIRUSES ARE COMPOSED OF AT LEAST THREE MEMBERS, INCLUDING THE HTLV-I VIRUS WHICH IS THE ETIOLOGIC AGENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA AND THE RECENTLY WELL-CHARACTERIZED ...

    SBIR Phase I 1985 Department of Health and Human Services
  9. NON-A, NON-B (NANB) HEPATITIS IS A MAJOR CAUSE OF LIVER DISEASE IN BOTH THE DEVELOPED AND UNDEVELOPED COUNTRIES OF THE WORLD.

    Amount: $50,000.00

    NON-A, NON-B (NANB) HEPATITIS IS A MAJOR CAUSE OF LIVER DISEASE IN BOTH THE DEVELOPED AND UNDEVELOPED COUNTRIES OF THE WORLD. WHILE A LARGE BODY OF DATA STRONGLY SUGGESTS AN INFECTIOUS AGENT, EFFORTS ...

    SBIR Phase I 1985 Department of Health and Human Services
  10. THE ESSENTIAL PLAN OF THIS PROPOSAL IS TO USE OOCYTE MICROINJECTION TO CREATE STRAINS OF MICE THAT ARE TOLERANT TO THE SPECIES-SPECIFIC DETERMINANTS THAT DISTINGUISH HUMAN CLASS I, DR, DC, OR SB ANTIGENS AS A GROUP FROM THEIR MURINE ANALOGUES INDEPENDENT

    Amount: $50,000.00

    THE ESSENTIAL PLAN OF THIS PROPOSAL IS TO USE OOCYTE MICROINJECTION TO CREATE STRAINS OF MICE THAT ARE TOLERANT TO THE SPECIES-SPECIFIC DETERMINANTS THAT DISTINGUISH HUMAN CLASS I, DR, DC, OR SB ANTIG ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government